New World TMT

New World TMT Limited is the investment arm of the New World Group, a major Hong Kong-based conglomerate. While its name reflects a primary focus on the technology, media, and telecommunications (TMT) sectors, the company has established a significant presence in the life sciences and healthcare industries through strategic investments. It is notably recognized for its role as a key investor in biotechnology firms such as Adagene, where it has led and participated in multiple funding rounds. New World TMT provides capital, management support, and strategic partnerships to innovative enterprises across China and the Asia-Pacific region, focusing on high-growth sectors including antibody discovery and medical technology.